You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 6, June 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Choroidal Neovascularization
 •Macular Degeneration
 •Articles for Residents
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Large–Spot Size Transpupillary Thermotherapy for the Treatment of Occult Choroidal Neovascularization Associated With Age-Related Macular Degeneration

Allen B. Thach, MD; Jack O. Sipperley, MD; Pravin U. Dugel, MD; Scott R. Sneed, MD; Donald W. Park, MD; Jennifer Cornelius, BS

Arch Ophthalmol. 2003;121:817-820.

Objective  To describe the outcome of patients with occult choroidal neovascularization in age-related macular degeneration treated with transpupillary thermotherapy.

Design  Prospective, nonrandomized, nonmasked case series.

Methods  All patients with age-related macular degeneration with a predominantly occult choroidal neovascular membrane and an initial visual acuity of 20/400 or better were offered treatment using transpupillary thermotherapy. The treatment consisted of using a diode laser, a spot size of about 3000 to 6000 µm delivered over 60 seconds, and a power of 600 to 1000 mW.

Main Outcome Measures:  A stable, improved, or worsened visual acuity and the need for additional treatment.

Results  Sixty-nine patients were treated. All patients have been followed up for at least 6 months. At the 6-, 9-, and 12-month follow-up visits, 71% of patients have stable or improved visual acuity and 29% have lost 2 or more lines of visual acuity on the Snellen letter chart.

Conclusion  Large–spot size transpupillary thermotherapy is effective in stabilizing the visual acuity in those patients who have occult choroidal neovascularization due to age-related macular degeneration.


From the Retinal Consultants of Arizona, Phoenix.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A prospective randomised study on low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration
Odergren et al.
Br J Ophthalmol 2008;92:757-761.
ABSTRACT | FULL TEXT  

Long term results after transpupillary thermotherapy in eyes with occult choroidal neovascularisation associated with age related macular degeneration: a prospective trial
Stolba et al.
Br J Ophthalmol 2006;90:158-161.
ABSTRACT | FULL TEXT  

Large Spot Transpupillary Thermotherapy for Occult Choroidal Neovascularization
Spaide et al.
Arch Ophthalmol 2005;123:1272-1273.
FULL TEXT  

Changes in Multifocal Electroretinograms Induced by Transpupillary Thermotherapy
Shimada and Horiguchi
Arch Ophthalmol 2005;123:1066-1072.
ABSTRACT | FULL TEXT  

Retinal Temperature Increase during Transpupillary Thermotherapy: Effects of Pigmentation, Subretinal Blood, and Choroidal Blood Flow
Ibarra et al.
IOVS 2004;45:3678-3682.
ABSTRACT | FULL TEXT  

Subthreshold Transpupillary Thermotherapy Reduces Experimental Choroidal Neovascularization in the Mouse without Collateral Damage to the Neural Retina
Ming et al.
IOVS 2004;45:1969-1974.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.